Stockreport

Dr. Reddy's biosimilar for Bristol's Orencia undergoes FDA review [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF for a biosimilar targeting Orencia, a blockbuster arthritis therapy marketed by Bristol-Myers Squibb ( BMY If approved, the product named DRL_AB Newsletters for Ever [Read more]